ArticleDiscover oncology2025

Gelsolin (GSN) as a key regulator in estrogen receptor-positive breast cancer: implications for prognosis, chemotherapy sensitivity, and immune infiltration.

Mian Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.